Briefs and reports

  1. Home
  2. >
  3. Results
  4. >
  5. Briefs and reports

Policy briefs

In 2019, a series of policy briefs were developed for the 1st list of HBM4EU priority substances. These are based primarily on the scoping documents and the reports on results produced under HBM4EU on each HBM4EU priority substance. The policy briefs are timed to target specific policy processes at the European level and within the Member States, including REACH and relevant sectoral policies.

The policy briefs cover areas such as toxicity, exposure, and policy status. In addition, a policy-relevant synthesis of the overall results derived from the project activities is delivered at the end of the project. The HBM4EU partners will work with the EU Policy Board to ensure that evidence can be brought into decision-making processes in a timely fashion. In some cases, policy briefs may be confidential and shared with a limited group of risk assessors and/or policymakers. The policy briefs are available on the substance’s web pages, under the Legislative status in the European Union section.

The results from our 1st list of priority substances have been available since 2019, and the 2nd list from 2020. In 2022, we will produce update final end-of-project policy briefs for all of the 18 HBM4EU priority substances/groups that will build on what is already available and capture any updates in legislation and further relevant research results.

The following policy briefs are now available:

Research briefs

In 2020, a series of research briefs aimed at informing scientists and policymakers will be published with updates on specific areas in the HBM4EU project.

These research briefs are already available for:


  •  ‘The role of human biomonitoring in assessing and managing chemical risks in the Nordic countries. HBM4EU and its continuation in PARC”. Please click here to read it. This report followed the Nordic workshop in March, on how to optimize the communication between scientists and authorities regarding use of HBM data in a regulatory context, with special attention given to the upcoming PARC initiative, and to promote Nordic collaborations in science and training.
  • Rapid Response Mechanism
    • In October 2018, DG SANTE submitted to HBM4EU an urgent request for information related to Copper (Cu) compounds, via the online Rapid Response Mechanism (RRM). This request relates to the renewal of approval of Copper compounds as active substances for plant protection products. HBM4EU was requested to assess human biomonitoring data and to establish whether all Cu compounds are similarly absorbed and excreted, whether Cu compounds used as plant protection products are more contributing to the burden than other sources and whether a cumulative exposure assessment can realistically bring an added-value to the risk assessment of Cu.
      The results’ report is available here.

Aligned studies

Within HBM4EU (ongoing) HBM studies are aligned and brought together under the joint HBM4EU survey to collect recent exposure data of EU citizens. The joint HBM4EU survey targets 3 age groups children (6-11 years), teenagers (12-19 years) and adults (20-39 years). Depending on the age group, internal exposure to phthalates and substitute Hexamoll® DINCH, brominated and organophosphorus flame retardants, per-/poly- fluorinated compounds (PFAS), cadmium (cd), bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, pesticides, mycotoxins, acrylamide and UV-filters (benzophenones) will be assessed.

The first results from the aligned studies are expected in 2021.

For the communication and dissemination of results other than scientific articles a workflow has been developed detailing a stepwise approach that should be followed to ensure all relevant partners are included in the process.

A timeline of when the data from the aligned studies is expected can be consulted here

Information on the procedure how to get access to the data can be consulted here